The European Patients Academy (EUPATI) will better inform patients about medicines R&D and the complexity of new treatment development, and train them about becoming partners in the development process. We will provide scientifically reliable, objective and comprehensive information to patients and patient advocates. We will increase the capacity of patients to be effective partners and advisors, whether it be in clinical trials, with regulatory authorities or in ethics committees. The project is led by the European Patients’ Forum and is comprised of a unique combination of pan-European patient organisations, academic and not-for-profit groups expert in patient and public engagement, and EFPIA companies. EUPATI will provide the tools for empowerment and offer meaningful involvement and engagement in medicines innovation and safety, as well as access to treatments.